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Quantitative response-response relationships 
A B S T R A C T   
A number of epigenetic modulating chemicals are known to affect multiple generations of a population from a 
single ancestral exposure, thus posing transgenerational hazards. The present study aimed to establish a high- 
throughput (HT) analytical workflow for cost-efficient concentration-response analysis of epigenetic and 
phenotypic effects, and to support the development of novel Adverse Outcome Pathway (AOP) networks for DNA 
methyltransferase (DNMT) inhibitor-mediated transgenerational effects on aquatic organisms. The model DNMT 
inhibitor 5-azacytidine (5AC) and the model freshwater crustacean Daphnia magna were used to generate new 
experimental data and served as prototypes to construct AOPs for aquatic organisms. Targeted HT bioassays 
(DNMT ELISA, MS-HRM and qPCR) in combination with multigenerational ecotoxicity tests revealed 
concentration-dependent transgenerational (F0-F3) effects of 5AC on total DNMT activity, DNA promoter 
methylation, gene body methylation, gene transcription and reproduction. Top sensitive toxicity pathways 
related to 5AC exposure, such as apoptosis and DNA damage responses were identified in both F0 and F3 using 
Gaussian Bayesian network modeling. Two novel epigenetic AOP networks on DNMT inhibitor mediated one- 
generational and transgenerational effects were developed for aquatic organisms and assessed for the weight 
of evidence. The new HT analytical workflow and AOPs can facilitate future ecological hazard assessment of 
epigenetic modulating chemicals.   
1. Introduction 
Heritable epigenetic marks, such as DNA methylation and histone 
modifications can in many cases reflect the life-time exposure history of 
an organism to environmental stressors (Mirbahai and Chipman, 2014). 
Among the epigenetic marks, DNA methylation is considered a master 
regulator of gene expression in eukaryotes (Law and Jacobsen, 2010) 
and has been frequently used as an (eco)toxicological biomarker to 
indicate effects of epigenetic modulators (Vandegehuchte and Janssen, 
2011; Kamstra et al., 2015; Meehan et al., 2018). While the rapid 
development of OMICS techniques allows measurements of 
genome-wide DNA methylation and gene expression profiles, the high 
costs for such analyses still limit our ability to fully understand the 
epigenetic changes across doses/concentrations of a stressor, exposure 
durations and multiple generations in a population. In addition to 
high-content (HC) OMICS tools, targeted high-throughput (HT) bio-
assays are also needed, allowing the inclusion of more life stages of an 
organism and exposure conditions of a stressor in the analysis to yield 
comparative dose/concentration-response data on a temporal scale. 
Such data can greatly facilitate the development of predictive (eco) 
toxicological approaches, such as Adverse Outcome Pathways (AOPs) 
for more efficient chemical safety assessment (Villeneuve et al., 2019). 
Adverse Outcome Pathway (AOP) was introduced as a framework to 
assemble, integrate, evaluate and visualize toxicological data and 
knowledge relevant for regulatory-relevant adverse effects (Ankley 
* Corresponding author. 
E-mail address: you.song@niva.no (Y. Song).  
Contents lists available at ScienceDirect 
Journal of Hazardous Materials 
journal homepage: www.elsevier.com/locate/jhazmat 
https://doi.org/10.1016/j.jhazmat.2020.124490 
Received 10 July 2020; Received in revised form 26 October 2020; Accepted 3 November 2020   
Journal of Hazardous Materials 408 (2021) 124490
2
et al., 2010). An AOP causally links the molecular initiating event (MIE) 
of a chemical with its biological target, a cascade of key downstream 
events (KEs) at increasing levels of biological organization, and an 
adverse outcome (AO) into a pathway or pathway network using 
available information from relevant (forecaster) species and prototypi-
cal stressors. The essentiality of the KEs and the strength of the causal 
linkages (key event relationships, KERs) can be evaluated by Weight of 
Evidence (WoE) considerations (Becker et al., 2015). The applicability 
domains of an AOP can be further expanded to other species (taxonomic 
applicability) based on their phylogenetic similarities, and to other 
chemicals (chemical applicability) based on their structure-activity 
properties (Fay et al., 2017). Effects of epigenetic modulators are 
starting to be considered in the AOP framework in recent years (Angrish 
et al., 2018; Willett, 2018), however, the initial AOPs proposed are 
human-centric. Efforts to develop epigenetic AOPs for non-human but 
ecologically important species may greatly facilitate mechanistic un-
derstanding of epigenetic transgenerational effects induced by different 
environmental stressors and assist ecological hazard assessment of 
epigenetic modulating chemicals. 
Among the epigenetic modulators, DNA methyltransferase (DNMT) 
inhibitors are a group of cytosine analogues with a common mechanism 
of action of hypomethylating cytosines in DNA. DNMT inhibitors, such 
as azacytidine and decitabine suppress DNMT activity by covalently 
trapping DNMT to the DNA incorporated cytosine analogues followed by 
degradation and subsequent DNA hypomethylation in organisms 
(Gnyszka et al., 2013). On the basis of this mechanism of action, DNMT 
inhibitors have been developed as medicines to treat oncological dis-
eases by re-activating silenced anti-cancer genes such as tumor protein 
TP53 (Gnyszka et al., 2013). These chemicals, however, have also been 
reported to have negative impacts on organisms. It has been realized 
that incorporation of DNMT inhibitors such as azacytidine into the 
cellular DNA replication machinery can lead to sequestration of DNMTs 
through formation of covalent bond between the carbon-6 atom of the 
cytosine ring and cysteine thiolate of DNMTs (Santi et al., 1984; Chen 
et al., 1991). The formation of DNA-enzyme adducts is irreversible, as 
the beta-elimination of this bond via the cabon-5 atom is blocked by 
azacytosine (Stresemann and Lyko, 2008). This subsequently jeopar-
dizes the normal functions of DNA and triggers DNA damage responses 
(Kiziltepe et al., 2007). The documented effects of DNMT inhibitors 
include induction of DNA strand breaks (Covey et al., 1986; Kiziltepe 
et al., 2007; Palii et al., 2008), activation of excessive apoptosis (Mur-
akami et al., 1995; Kiziltepe et al., 2007; Khan et al., 2008; Ghanim 
et al., 2012), teratogenic effects, sex shifts and multigenerational growth 
retardation (Kamstra et al., 2017; Ribas et al., 2017). Although a number 
of studies have been conducted to understand the effects of DNMT in-
hibitors on human cells and terrestrial mammals, whether these chem-
icals are hazardous to human in a long-term perspective remains 
inconclusive, and relatively little is known about their ecological haz-
ards to aquatic organisms. 
The water flea Daphnia have been widely used as aquatic inverte-
brate models for environmental epigenetic research (Harris et al., 2012; 
Jeremias et al., 2020) and AOP development (Song et al., 2017, 2020a, 
2020b) due to their high ecological relevance, rapid reproductive cycles 
with genetically identical clones via parthenogenesis, ease to maintain 
under laboratory conditions and worldwide use as a standard OECD 
regulatory toxicity testing species (OECD, 2012). The present study, 
therefore used Daphnia magna as a prototypical species to investigate the 
transgenerational effects of a model DNMT inhibitor, 5-azacytidine 
Abbreviations 
18 s 18S ribosomal RNA 
5AC 5-azacytidine 
Acin1 Apoptotic chromatin condensation inducer in the nucleus 
Actin Actin, alpha skeletal muscle 
Aifm1 Apoptosis-inducing factor 1, mitochondrial 
AO Adverse outcome 
AOP Adverse outcome pathway 
Atm Serine/threonine-protein kinase ATM 
Atp2c1 Calcium-transporting ATPase type 2 C member 
ATR Ataxia telangiectasia and Rad3-related protein 




Cdk Cyclin-dependent kinase 
Dapk Death associated protein kinase 
Dmrta1 Doublesex- and mab-3-related transcription factor A1 
DNMT DNA methyltransferase 
Dnmt1 DNA (cytosine-5)-methyltransferase 1 
Dnmt3a1 DNA (cytosine-5)-methyltransferase 3A1 
Dnmt3a2 DNA (cytosine-5)-methyltransferase 3A2 
DSB Double-strand break 
ELISA Enzyme-linked immunosorbent assay 
Galt Galactose-1-phosphate uridylyltransferase 
GBN Gaussian Bayesian network 
Gnmt Glycine N-methyltransferase 
Gsta4 Glutathione S-transferase A4 
HC High-content 
Hcfc1 Host cell factor 1 
HDI Highest density interval 
HT High-throughput 
KE Key event 
KER Key event relationship 
Ku70 ATP-dependent DNA helicase 2 subunit 
Limch1 LIM and calponin domains-containing protein 
Mat S-adenosylmethionine synthase 
Mdm2 E3 ubiquitin-protein ligase Mdm2 
Met Methoprene tolerant 
Metk S-adenosylmethionine synthase 
MIE Molecular initiating event 
Ms Methionine synthase,EC:2.1.1.13/sw 
MSHRM Methylation sensitive high resolution melt 
Mthfr Methylenetetrahydrofolate reductase 
Mtrr Methionine synthase reductase 
Mycbp c-Myc-binding protein 
Nrf2 Nuclear factor erythroid 2-related factor 2 
NTS Net temperature shift 
OCM One-carbon metabolism 
OECD Organisation for Economic Co-operation and Development 
P53 Cellular tumor antigen p53 
qPCR Quantitative real-time reverse transcription polymerase 
chain reaction 
Rad50 DNA repair protein RAD50 
Rev1 DNA repair protein REV1 
Sahh Adenosylhomocysteinase adohcyaseec hydrolase 
SAM S-adenosylmethionine 
SeqAPASS Sequence Alignment to Predict Across Species 
Susceptibility 
Tbp TATA-box-binding protein 
Tet2 Methylcytosine dioxygenase TET2 
Tnfaip8 Tumor necrosis factor alpha-induced protein 8 protein 3 
Vtg1 Vitellogenin-1 
Vtg2 Vitellogenin-2 
WoE Weight of evidence  
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(5AC), on aquatic organisms and to develop AOPs. High-throughput 
bioassays in combination with Gaussian Bayesian network (GBN) anal-
ysis were employed to identify key toxicity pathways associated with 
5AC toxicity, and to support development and WoE assessment of 
epigenetic AOP networks. The general hypothesis of the study was that 
exposure to 5AC could induce transgenerational effects on DNA 
methylation, gene transcription and reproduction in D. magna along 
defined AOPs. The main objectives of the study were to: 1) understand 
the relationships between chemical-mediated DNMT inhibition, DNA 
promoter methylation, gene body methylation, gene expression and 
multigenerational reproductive quality in D. magna; 2) develop and 
evaluate novel epigenetic AOP networks for DNMT inhibitor-mediated 
transgenerational effects on aquatic organisms. 
2. Materials and methods 
2.1. Daphnia culture 
Daphnia magna DHI strain (DHI Water & Environment, Hørsholm, 
Denmark) were cultured in 1 L glass beakers (20 daphnids/800 mL M7 
medium) under favorable conditions (temperature 20 ± 1 ◦C, light:dark 
16 h:8 h, pH 7.8 ± 0.2, dissolved oxygen >7 mg/L, density 1 daphnid per 
40 mL medium), according to the principles of the OECD Test Guideline 
211 (OECD, 2012). The culture media were renewed every two days and 
offspring were removed to avoid potential crowding effect. The daph-
nids were daily fed with concentrated green algae Raphidocelis sub-
capitata, corresponding to 0.1 mg carbon/daphnid/day (OECD, 2012). 
2.2. Test chemical 
The model DNA methyltransferase (DNMT) inhibitor 5-azacytidine 
(5AC, CAS 320–67–2, purity ≥ 98%) was purchased from Sigma- 
Aldrich (St. Louis, USA) and stored at − 20 ◦C. The test solutions of 
5AC were freshly prepared shortly before the exposure/medium renewal 
due to the short half-life of this chemical. A 0.05 mol/L (M) stock solution 
was prepared first by dissolving 5AC in M7 medium. The final test solu-
tions were made by diluting different volumes of the stock solution in M7 
medium. The nominal exposure concentrations of 5AC were 5, 10, 20, 40 
and 80 µM. This concentration range was chosen, as they were not ex-
pected to cause mortality in adult D. magna during 7 days exposure, and as 
low as 10 mg/L (approx. 40 µM) was reported to significantly reduce the 
fecundity in D. magna (Lindeman et al., 2019). In addition, a control 
containing pure medium was also included in the tests. 
2.3. Exposure and sampling 
The laboratory conditions for exposure studies were identical to that 
used for culturing, except that small (100 mL) glass beakers were used. A 
multigenerational test was set up to investigate the transgenerational 
effects of 5AC on different endpoints (Appendix, Fig. A1). Age synchro-
nized (14–15d) adult female D. magna was used for exposure studies. Two 
daphnids were placed in the same test beaker and exposed in 80 mL of test 
solutions for 7 days (Appendix, Fig. A1), according to a previously 
described short-term screening (STS) protocol (Abe et al., 2015). A total of 
20 beakers per treatment group (n = 20) were included at the start of the 
test (total number of beakers for 6 treatment groups: 120). Each beaker 
was considered an independent biological replicate and all beakers were 
randomized every two days. After 7 days, D. magna from 14 test beakers 
were immediately sampled. One individual was snap-frozen in liquid ni-
trogen and stored at − 80 ◦C until DNA analysis (1 daphnid per replicate, 
n = 6). The other one was sampled in 100 µL of RNAlater (Qiagen, Hilden, 
Germany), stored at 4 ◦C overnight and further stored at − 80 ◦C until 
RNA analysis (1 daphnid per replicate, n = 6). Eight beakers were pooled 
into 4 replicates to have sufficient materials, snap-frozen in liquid nitro-
gen and stored at − 80 ◦C until total DNMT activity analysis (4 daphnids 
per replicate, n = 4). Animals in the remaining six replicates were briefly 
rinsed and transferred to new beakers containing clean media (2 daph-
nids/80 mL medium/beaker) for a 7-day recovery test (Appendix, 
Fig. A1). All replicates were sampled for DNA methylation (1 daphni-
d/replicate) and transcriptional (1 daphnid/replicate) analyses immedi-
ately after the recovery period. F1 neonates (<24 h old) were collected 
from the second brood of F0 (i.e., from the 6 replicates immediately 
sampled after exposure) during the exposure, whereas F2 and F3 offspring 
were collected from the last broods before termination of the F1 and F2 
test, respectively (Appendix, Fig. A1). From F1, each generation (n = 6, 1 
daphnid/40 mL medium/beaker) was tested for 21 days (Appendix, 
Fig. A1), according to the principles of the OECD D. magna Reproduction 
Test (OECD, 2012). Immediately after the F3 test, D. magna were sampled 
for DNA methylation (1 daphnid/replicate) analysis, but not for tran-
scriptional analysis due to a lack of sufficient material as a result of 
reduced fecundity after exposure to 5AC. Cumulative fecundity (total 
number of viable offspring) was recorded for all generations. The test 
solutions were renewed every two days and D. magna were fed daily with 
concentrated green algae R. subcapitata, corresponding to 0.1 mg car-
bon/daphnid/day (OECD, 2012). All test beakers were randomized to 
avoid potential bias. 
2.4. HT-MSHRM 
A high-throughput (384-well microplate format) methylation sensi-
tive high-resolution melt (HT-MSHRM) assay was downscaled for low 
input materials (i.e., DNA from single D. magna) and used to determine 
locus-specific promoter and gene body DNA methylation of 16 genes in 
F0 after exposure and recovery, and in F3 D. magna. The test genes were 
well-known biomarker genes or key regulators involved in major bio-
logical pathways, including one carbon metabolism (Dnmt3a2, Gnmt, 
Tet2, see Abbreviations for gene full names), apoptotic signaling (Aifm1, 
Casp2, Dapk, Mycbp), DNA damage responses (Atm), cell cycle regulation 
(Cdk, Hcfc1), oxidative stress responses (Nrf2), cell migration (Limch1), 
juvenile hormone signaling (Met, Dmrta4), calcium signaling (Atp2c1) 
and small sugar metabolism (Galt). The gene body sequences were ob-
tained from the WFleaBase (http://wfleabase.org/) using the available 
D. magna genome and associated gene models (Orsini et al., 2016), 
whereas the promoter sequences were considered as 1000 base pairs 
(bp) upstream of transcription start site (TSS), as previously described 
(Lindeman et al., 2019). The promoters and the genes with genomic 
locations and associated wfleabase IDs are listed in Appendix (Tables A1 
& A2). Primers for promoter (Appendix, Table A1) and gene body 
(Appendix, Table A2) methylation analyses were designed using Meth-
Primer v1.0 (https://www.urogene.org/cgi-bin/methprimer/methpr 
imer.cgi) (Li and Dahiya, 2002). Primers were designed for amplifica-
tion of both methylated and unmethylated DNA. An Agilent Bioanalyzer 
and High Sensitivity DNA Kit (Agilent technologies, Santa Clara, USA) 
was used to assess the specificity of PCR products and primer dimers. 
Unqualified primers were excluded and replaced with new pairs. All PCR 
products were specific and of the expected size (data not shown). 
Genomic DNA (gDNA) from single D. magna was isolated using a 
Quick-DNA™ Tissue/Insect Microprep Kit (Zymo Research, Irvine, 
USA). The DNA yield (>100 ng) and purity (260/280 > 1.8) were 
determined using a Nanodrop® ND-1000 spectrophotometer (Nanodrop 
Technologies, Wilminton, USA). The purified gDNA was diluted and 
bisulfite converted using an EZ DNA Methylation-Lightning™ Kit 
(Zymo). The conversion efficiency was higher than 99.5% and the DNA 
recovery rate was higher than 80%, according to the manufacturer’s 
protocol. The human HCT116 DKO methylated (100%) DNA (Zymo) 
was used as a quality control for bisulfite conversion. An unmethylated 
(0%) DNA standard was made by whole genome amplification (WGA) of 
pooled D. magna gDNA using a REPLI-g Mini/Midi Kit (Qiagen), 
following the producer’s instructions. 
The HT-MSHRM assay (n = 6) was performed using the Bio-Rad 
CFX384 platform (Bio-Rad Laboratories, Hercules, USA). A Biomek 
3000 Laboratory Automation Workstation (PerkinElmer, Waltham, 
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USA) was employed for high-throughput liquid handling. The PCR 
amplification reaction (10 µL) contained 2.5 µL (0.4 ng/µL) of bisulfite 
converted DNA samples or unmethylated DNA standard, 5 µL of 
ZymoTaq™ qPCR PreMix (Zymo) and 2.5 µL of 200 nM forward and 
reverse primer mixture. The PCR cycles were set to: 1) hot start at 95 ◦C 
for 15 min; 2) 45 cycles of: denature at 94 ◦C for 0.5 min, annealing at 
the primer-specific optimal temperature (Ta) for 0.5 min, extension at 
63 ◦C for 1 min; 3) final extension at 63 ◦C for 10 min. A high-resolution 
melt analysis was performed between 63 and 95 ◦C with a temperature 
increment of 0.1 ◦C. 
The raw HT-MSHRM data was analyzed using the CFX Manager v3.0 
and Precision Melt Analysis software v1.2 (Bio-Rad). Net Temperature 
Shift (NTS) was calculated by comparing the melt curve of a target 
sample with that of a non-methylated standard, based on the principles 
of a previous protocol (Kamstra et al., 2014). The NTS in the exposed 
groups were further normalized to the control to calculate fold changes 
prior to statistical analysis. 
2.5. HT-qPCR 
A high-throughput (384-well microplate format) quantitative real- 
time reverse-transcription polymerase chain reaction (HT-qPCR) was 
employed to measure transcriptional changes of 34 selected genes 
(Appendix, Table A3). The test genes are well-known biomarker genes or 
key regulators involved in major biological pathways, including one 
carbon metabolism (Dnmt1, Dnmt3a1, Dnmt3a2, Gnmt, Mat, Ms, Mthfr, 
Mtrr, Sahh, Tet2), apoptotic signaling (Acin1, Aifm1, Casp1, Casp2, 
Casp8, Dapk, Mycbp, Tnfaip8), DNA damage responses (Atm, Ku70, 
Mdm2, P53, Rad50, Rev1), cell cycle regulation (Cdk, Hcfc1), oxidative 
stress responses (Nrf2, Gsta4), cell migration (Limch1), juvenile hormone 
signaling (Met, Dmrta4), embryo development (Vtg1), calcium signaling 
(Atp2c1) and small sugar metabolism (Galt). Primers (Appendix, 
Table A3) were designed using Primer3 v4.0.0 (http://primer3.ut.ee/) 
and ordered from Thermo Fisher Scientific (Waltham, USA). The 
optimal annealing temperatures of the primers were obtained prior to 
sample analysis (Appendix, Table A3). 
Total RNA was isolated using a ZR Tissue & Insect RNA MicroPrep™ 
kit (Zymo), as previously described (Song et al., 2016). The yield (>500 
ng) and purity (260/280 > 1.8) of the RNA samples were measured 
using a Nanodrop® ND-1000 spectrophotometer (Nanodrop). The 
integrity of the RNA was checked using an Agilent Bioanalyzer and RNA 
6000 Nano chips (Song et al., 2016). Qualified samples with clear RNA 
peaks and flat baseline were stored at − 80 ◦C until HT-qPCR analysis. 
The HT-qPCR assay (n = 6) was performed using the Bio-Rad CFX384 
platform (Bio-Rad), as previously described (Song et al., 2016). A Biomek 
3000 Laboratory Automation Workstation (PerkinElmer) was employed 
for high-throughput liquid handling. In brief, 600 ng total RNA was 
reversely transcribed into cDNA using qScript™ cDNA SuperMix (Quanta 
BioSciences, Gaithersburg, USA). The qPCR reaction (10 µL) consisted of 
2.5 µL diluted cDNA template (1 ng/µL, total mass 2.5 ng), 5 µL of 
PerfeCTa® SYBR® Green FastMix® (Quanta BioSciences) and 2.5 µL of 
forward and reverse primer mixture (400 nM). A series of diluted cDNA 
(12.5, 6.25, 31.13, 1.56, 0.78, 0.39 ng) were made from pooled D. magna 
RNA and were included to generate standard curves for determination of 
amplification efficiencies (E) and correlation coefficient (R2). A 
no-reverse-transcriptase control (NRT) and a non-template control (NTC) 
were included as additional quality controls. The thermo cycles for qPCR 
amplification were set to: 1) 95 ◦C for 3 min; 2) 40 cycles of 95 ◦C for 20 s, 
primer-specific Ta for 20 s, 72 ◦C for 30 s; 3) a melt curve analysis for 30 s 
between 65 and 90 ºC with an increment of 0.5 ºC. Tests with amplifi-
cation efficiency between 90% and 105% and correlation coefficient (R2) 
between 0.98 and 1 were considered valid. The relative expression of the 
target gene was calculated based on a combination of efficiency and the 
threshold cycle (Cq) value according to the Pfaffl Method (Pfaffl, 2001), 
and normalized to the geometric mean expression of the reference genes 
Actin alpha skeletal muscle (Actin), 18 S ribosomal RNA (18 s) and 
TATA-box-binding protein (Tbp), based on the ΔΔCq method (Vande-
sompele et al., 2002). 
2.6. DNMT ELISA 
A high-throughput (96-well microplate format) enzyme-linked 
immunosorbent assay (ELISA) was employed to determine the total 
activity of DNMTs in F0 D. magna after the exposure. Nuclei were 
extracted from pooled D. magna (4 individuals) using an EpiQuik™ 
Nuclear Extraction Kit I (Epigentek, New York, USA). The total nuclear 
protein yield was determined using a Coomassie Plus (Bradford) Assay 
Kit (Thermo-Fisher Scientific, Waltham, USA), based on the Bradford 
method (Bradford, 1976). The total DNMT activity HT-ELISA (n = 4) 
was performed using a fluorometric EpiQuik™ DNMT Activity/Inhibi-
tion Assay Ultra Kit (Epigentek). All assay procedures were performed 
according to the manufacturer’s protocols. The absolute DNMT activ-
ities (RFU/h/mg nuclear protein) were calculated and further normal-
ized to the control to calculate fold changes. 
2.7. Basic statistical analyses 
A ROUT test (Motulsky and Brown, 2006) was performed first to 
eliminate outliers in the raw data prior to normality and equal variance 
assessment. One-way analysis of variance (ANOVA, normal distribution 
and equal variance) followed with Tukey post-hoc test, or Kruskal-Wallis 
non-parametric test (no normality or equal variance) followed with 
Dunn’s post-hoc test was used to determine statistical differences (p <
0.05) between treatment groups. The basic statistical analyses were 
performed in Graphpad Prism v8 (Graphpad Software Inc., San Diego, 
USA). 
2.8. Gaussian Bayesian network analysis 
The quantitative relationships between key events in a toxicity 
pathway were evaluated using Gaussian Bayesian network (GBN). The 
GBN approach offers algorithms for prediction and inference where all 
variables are continuous and defined by a Gaussian prior distribution or 
a Gaussian conditional distribution. The linear additive relationship was 
assumed between the KEs, which was supported by the scatter plots and 
has good mathematical properties such as tractability and the avail-
ability of closed-form results for the inference procedures (Buja et al., 
1989). The average and variation of the GBN coefficients were estimated 
using the resampling method. First, different data points of F0 DNMT 
activity, F0 promoter methylation, F0 gene expression, and F0 fecundity 
values within each of the 6 treatment groups were randomly sampled 
with replacement. A total of 180 observations were obtained to build a 
GBN and estimate the corresponding linear coefficients for the arcs of 
the GBN. Second, the procedures were repeated 10,000 times to 
construct 10,000 GBNs which were used to estimate the coefficients of 
the GBNs. Third, mean, median, and 95% highest density interval (HDI) 
(Turkkan and Pham-Gia, 1993) were calculated based on the 10,000 
estimates. The 95% HDIs that did not include 0 were considered sta-
tistically significant (p < 0.05) (Appendix, Table A4). Multiplicative 
coefficient was calculated for each hypothetical toxicity pathway to 
indicate the overall sensitivity of the pathway subject to changes in 5AC 
concentrations (Appendix, Table A5). The toxicity pathways were 
ranked by their absolute multiplicative coefficients. The higher absolute 
value indicates higher sensitivity of the pathway. The parameters of the 
second toxicity pathway network for transgenerational effects (i.e. 
F0-F3) were also estimated using the same method (Appendix, Table A6 
& A7). All the analyses were performed in R software 4.01 (R Founda-
tion for Statistical Computing, Vienna, Austria, https://www.R-project. 
org/). 
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2.9. AOP assembly and weight of evidence assessment 
Conceptual AOPs were assembled following OECD’s handbook for 
AOP development and assessment (OECD, 2018). The WoE of the AOPs 
was assessed based on the Bradford Hill Considerations (Becker et al., 
2015). The confidence levels of the KEs and KERs were scored as “High”, 
“Moderate” or “Low”, according to OECD’s AOP handbook (OECD, 
2018). To expand the taxonomic applicability domain of the AOPs, the 
Sequence Alignment to Predict Across Species Susceptibility (SeqA-
PASS) tool (LaLone et al., 2016) was employed to identify susceptible 
species groups based on protein sequence similarities. Two D. magna 
proteins, Dnmt3 (GenBank acc. KZS08978.1) and Casp1 (GenBank acc. 
KZS14075.1) were used as query sequences for level 1 (primary amino 
acid sequence alignment) analysis in SeqAPASS, as these were the only 
D. magna proteins found in the database that were directly relevant for 
the AOPs. Dnmt3 was used to represent the MIE of the AOPs, whereas 
Casp1 was used to represent KE3 and KE9 of the AOPs. Furthermore, 
based on the level 1 analysis, the conserved domains of Dnmt3 (GenBank 
acc. cd11725) and Casp1 (GenBank acc. cd00032) were identified and 
used for level 2 (functional domain alignment) analysis. The chemical 
applicability domain of the AOPs was defined by data mining in the 
literature and public databases to collect a list of previously reported 
DNMT inhibiting chemicals. 
3. Results and discussion 
3.1. Molecular initiating event 
It has been widely accepted that DNMTs are the primary macromo-
lecular targets of 5AC (Stresemann and Lyko, 2008). Although inhibition 
of DNMTs by 5AC has been well documented for vertebrates (Strese-
mann and Lyko, 2008), the potency of this chemical to affect inverte-
brate DNMTs has been largely unknown. A multigenerational decrease 
in global DNA cytosine methylation has been previously observed 
following 5AC exposure (Vandegehuchte et al., 2010; Lindeman et al., 
2019), but as of yet no direct activity of DNMTs has been measured in 
D. magna. The present study showed that the total activity of DNMTs in 
F0 D. magna decreased in a concentration-dependent manner after 7 
days exposure to 5AC, with a significant reduction of approx. 40% at the 
highest concentration (Fig. 1). This is to date the first direct evidence to 
support 5AC mediated DNMT inhibition as a potential MIE in aquatic 
invertebrates. 
3.2. Key events 
3.2.1. DNA methylation 
Hypomethylation of genes as a general consequence of 5AC exposure 
in both vertebrates (Stresemann and Lyko, 2008) and D. magna (Lin-
deman et al., 2019), was also observed for the majority of the test genes 
in F0 after 7 days exposure to 40 and 80 uM 5AC in the present study 
(Fig. 2 & see SI-1 Fig. S2 for concentration-response curves). Several 
genes tested in the current analysis have also been previously reported 
to have reduced DNA methylation in D. magna after chronic exposure 
Fig. 1. Total DNA methyltransferase (DNMT) activity (n = 4) in F0 Daphnia 
magna after 7 days exposure to 5-azacytidine. * denotes significant difference 
from the corresponding control. 
Fig. 2. A heatmap displaying DNA promoter methylation (n = 6), gene body methylation (n = 6) and gene transcription (n = 6) in F0 Daphnia magna after 7 days 
exposure to 5-azacytidine, in F0 after 7 days recovery, and in F3. Each cell represents the log2 transformed mean fold change compared to the control. Red: increased 
compared to the control (0); green: decreased compared to the control. (For interpretation of the references to colour in this figure legend, the reader is referred to the 
web version of this article.) 
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(until releasing of the third brood) to 3.7 mg/L (approx. 15 µM) of 5AC 
(Athanasio et al., 2018), such as the cell migration regulator Limch1, the 
cell cycle regulators Hcfc1 and Cdk, and the plasma membrane calcium 
transporter Atp2c1. In contrast, no clear patterns of gene body methyl-
ation were identified (Fig. 2 and see Appendix, Fig. A2 for detailed 
concentration-response curves), except for the master regulator of 
oxidative response Nrf2 and Limch1 which showed significantly 
increased gene body methylation at the highest concentration and a 
clear concentration-dependent decrease in gene body methylation, 
respectively (Fig. 2 and Appendix, Fig. A2). 
Interestingly, after 7 days recovery, the majority of the genes dis-
played significantly increased promoter methylation at 80 µM (Fig. 2 
and Appendix, Fig. A2), whereas only the S-adenosylmethionine (SAM) 
regulator in the OCM Gnmt and the mitochondrial initiator of apoptotic 
Fig. 3. Violin plots displaying transcriptional responses of biomarker genes in F0 Daphnia magna after 7 days exposure to 5-azacytidine (n = 6) and after 7 days 
recovery (n = 6). * denotes significant difference from the control (0). 
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signaling pathway Afim1 had significant increases in gene body 
methylation at 80 and 10 µM, respectively (Fig. 2 and Appendix, 
Fig. A2). These findings clearly indicate that 5AC mediated promoter 
hypomethylation was reversible. It is plausible that certain plasticity 
mechanisms exist to reactivate the DNA methylation machinery and 
compensate for the excessive demethylation during exposure. 
In addition, transgenerational effects of 5AC on DNA methylation 
were also observed in the present study. In F3, most of the genes had 
increased promoter methylation at 40 and/or 80 µM (Fig. 2 and Ap-
pendix, Fig. A2), with exceptions of the DNA demethylation regulator 
Tet2, the apoptosis activator Casp2 and the regulator of small sugar 
metabolism Galt which showed reduced promoter methylation (Fig. 2 
and Appendix, Fig. A2). Significantly increased gene body methylation 
was found for Tet2 (20, 40 and 80 µM), Casp2 (20 and 80 µM) and Cdk 
(5 µM), whereas significantly reduced gene body methylation was 
identified for the DNA double-strand break (DSB) sensor Atm and the 
apoptosis regulator Dapk. 
3.2.2. Transcriptional responses 
It has been suggested that promoter methylation is in general associ-
ated with transcriptional suppression, whereas gene body methylation is 
normally correlated with increased gene expression (Moore et al., 2013). 
In the present study, the majority of the genes in F0 were significantly 
upregulated after 7 days exposure to 40 and/or 80 µM of 5AC, whereas 
downregulated after 7 days recovery (Figs. 2 and 3). Apparent inverse 
relationships between gene expression and promoter methylation were 
observed, whereas no clear patterns were identified between gene 
expression and gene body methylation (Fig. 2). Since the promoter is 
highly dynamic and smaller than a gene body which often spans multiple 
kilobases in length, differences in gene body methylation are more diffi-
cult to assess. In some invertebrates, methylated exons have been asso-
ciated with alternative splicing sites (Flores et al., 2012). Differential 
methylation at alternative splicing sites has been previously observed in 
Daphnia exposed to Microcystis aeruginosa (Asselman et al., 2017) and to 
salinity (Jeremias et al., 2018). Given the lack of clear patterns in both 
gene body methylation and its relation to gene expression, it seems that 
promoter methylation rather than gene body methylation is driving the 
transcriptional responses to 5AC. At the functional level, transcriptional 
responses of the 34 test genes indicate that multiple pathways, such as 
OCM, apoptotic signaling, DNA damage responses, cell cycle regulation, 
oxidative stress responses, cell migration, juvenile hormone signaling, 
embryo development, calcium signaling and small sugar metabolism 
(Galt) were activated after exposure to 5AC, whereas suppressed after the 
recovery period (Figs. 2 and 3). Exposure to 5AC is known to affect OCM 
(Krushkal et al., 2016), induce ATR-mediated DNA DSB responses and cell 
cycle regulation (Kiziltepe et al., 2007), and trigger both caspase depen-
dent and independent apoptotic pathways (Murakami et al., 1995; 
Kiziltepe et al., 2007) in mammalian cells. In D. magna, exposure to 
10 mg/L (approx. 41 µM) of 5AC for 7 days was reported to alter the 
expression of genes involved in OCM (Dnmt1, Dnmt3a2, Gnmt, Metk, Sahh, 
Mthfr), juvenile hormone signaling (Met) and embryo development (Vtg1, 
Vtg2) in F0 and F1, however, with dissimilar directions of regulation 
(Lindeman et al., 2019). Another study showed that after chronic expo-
sure (until releasing of the third brood) to 3.7 mg/L (approx. 15 µM) of 
5AC, both genes and metabolites involved in OCM (Mat, Ms, Sahh, Bhmt, 
Mtrr, Gnmt) were affected, albeit the responses were highly 
time-dependent (Athanasio et al., 2018). 
3.3. Adverse outcomes 
The adverse outcomes of 5AC have been documented for different 
species including D. magna. In the previous study by Vandegehuchte and 
coworkers, exposure to 5AC for 21 days significantly reduced repro-
duction in F0 D. magna, with a lowest-observed-effect-concentration 
(LOEC) of 16 mg/L (approx. 65 µM) corresponding to 54% reduction 
in cumulative fecundity (Vandegehuchte et al., 2010). A more recent 
study by Lindeman and colleagues also showed a significant reduction 
(12%) in cumulative fecundity in adult D. magna after 7 days exposure to 
10 mg/L (approx. 41 µM) of 5AC (Lindeman et al., 2019). In line with 
the previous knowledge, the present study has also demonstrated that 
after 7 days exposure, the reproduction in F0 D. magna decreased in a 
concentration-dependent manner, with exposure to 40 and 80 µM of 
5AC leading to a significant reduction in cumulative fecundity (Fig. 4). 
Interestingly, the 7 days recovery did not mitigate the effects of 5AC, 
with 40 and 80 µM of 5AC causing a more severe decline in fecundity 
(Fig. 4), thus indicating irreversible adverse effects of this chemical at 
the organismal level. 
Through a multigenerational design, the present study further 
revealed that parental (F0) exposure to 5AC also led to reduced repro-
duction in the three successive (F1–3) generations in D. magna, with the 
concentration-response curves of F1-F3 in general resembling that ob-
tained for F0 immediately after exposure (Fig. 4). As F3 is considered the 
Fig. 4. Concentration-response curves of cumulative fecundity in F0 Daphnia magna after 7 days exposure to 5-azacytidine (n = 12), cumulative fecundity in F0 after 
7 days recovery in clean media (n = 6), and 21 days cumulative fecundity in F1 (n = 6), F2 (n = 6) and F3 (n = 6). Data are presented as mean±SD. * denotes 
significant difference from the corresponding control. 
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first truly unexposed progeny in this exposure setup, the results clearly 
indicate transgenerational effects of 5AC on D. magna reproduction. 
Such transgenerational reproductive effects have not been documented 
for D. magna or other aquatic invertebrates, albeit a multigenerational 
study reported that parental exposure to 2.9 mg/L (approx. 12 µM) of 
5AC for 16 days led to significantly reduced reproduction in F1 
D. magna, whereas a non-significant decrease in reproduction was 
observed for F2 (Vandegehuchte et al., 2010). As no truly unexposed 
generation was investigated, this study could not confirm transgenera-
tional effects of the chemical. Although not well studied in crustaceans, 
the transgenerational effects of 5AC have been reported for other 
aquatic organisms. For example, exposure of parental zebrafish (Danio 
rerio) to 10 µM of 5AC during the early embryonic period 
(0–6 day-post-fertilization, dpf) led to a significant reduction in body 
length in unexposed F2 and a shifted sex ratio to males in F1 (Kamstra 
et al., 2017). In another study where zebrafish were exposed to 25 and 
75 µM of 5-aza-2’-deoxycytidine from 0 to 6 dpf, a shift towards females 
was found in F0 (Ribas et al., 2017). In addition, ovaria were analyzed 
for RNA expression with a number of differentially expressed genes 
related to reproduction (Ribas et al., 2017). However, no direct effect on 
fecundity was reported in this study (Ribas et al., 2017). 
3.4. Toxicity pathway characterization 
To identify the most sensitive (influential) pathways contributing to 
the 5 AC toxicity and use these for AOP development, quantitative re-
lationships between total DNMT activity, promoter methylation, gene 
expression and reproduction were established for the 16 genes (which 
have complete data) using the GBN approach (Appendix, Tables A4 & 
A6), and assembled into two hypothetical networks covering both F0 
(Fig. 5A) and F0-F3 transmission pathways (Fig. 5B). By calculating the 
multiplicative coefficient for each hypothetical pathway (Appendix, 
Tables A6 & A7), the overall relevance of the pathways subject to the 
5AC concentrations were ranked (Fig. 5). The results suggest that in the 
F0 network (Fig. 5A), the most sensitive (top 5) toxicity pathways were 
associated with cell migration (Limch1), apoptosis (Casp2), oxidative 
stress responses (Nrf2) and OCM (Gnmt, Dnmt3a2). In the F0-F3 network 
(Fig. 5B), the top 5 pathways were related to OCM (Dnmt3a2), apoptosis 
(Mycbp, Casp2, Aifm1) and DNA damage responses (Atm). On the basis of 
the current findings and existing knowledge on the mechanisms of ac-
tion of 5AC, it is likely that besides direct effects on OCM, 5AC mediated 
apoptosis and DNA damage were also major contributors to the observed 
reproductive effects. Interestingly, besides Dnmt3a2, the Casp2 pathway 
was scored highly relevant for both F0 and F0-F3 networks, potentially 
highlighting a key role of caspase-mediated apoptosis in 5AC mediated 
reproductive toxicity. In fact, previous studies have suggested causal 
Fig. 5. Bayesian network analysis of the 
F0 toxicity pathways (A) and F0 to F3 
transmission toxicity pathways (B) of 5- 
azacytidine in Daphnia magna. Aza_-
Conc: 5-azacytidine concentration; 
F0_DNMT: total enzymatic activity of 
DNMTs in F0; F0_PM: promoter 
methylation in F0; F0_GX: gene expres-
sion in F0; F3_PM: promoter methyl-
ation in F3; F0_Fec: fecundity in F0; 
F3_Fec: fecundity in F3. The numbers 
indicate pathway coefficients. The 
pathways are ranked by their absolute 
multiplicative coefficients from the top 
(highest value) to the bottom (lowest 
value).   
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relationships between somatic cell apoptosis, ovarian follicle integrity, 
oocyte apoptosis, oogenesis and fecundity in mammals (Hussein, 2005; 
Tiwari et al., 2015) and invertebrates (Song et al., 2020a). It is therefore 
highly plausible that the observed reproductive decline in the present 
study was a direct consequence of impaired oogenesis, possibly due to 
oocyte apoptosis and/or somatic cell apoptosis mediated ovarian follicle 
breakdown. On the basis of this, the observed epigenetic effects occur-
ring at the molecular level in the present study could be connected to the 
reported tissue/organ effects documented for D. magna via the common 
event of apoptosis. It should also be noted that the cell migration and 
oxidative stress responses pathways were also identified to be highly 
relevant for 5AC toxicity by the data-driven approach. These pathways 
may warrant further investigations. 
3.5. AOP development and evaluation 
3.5.1. AOP assembly 
On the basis of relevant toxicity pathways identified in the present 
study and existing AOPs related to DNA damage, apoptosis and repro-
ductive toxicity in the AOP repository database AOPWiki (https://aop 
wiki.org/, AOP#216), two new AOP networks on inhibition of DNMT 
activity leading to reduced population trajectory (Fig. 6) were assem-
bled and submitted to AOPWiki (AOP#336–341). In network 1 (Fig. 6), 
both DNMT inhibition mediated global hypomethylation and DNA DSB 
can trigger caspase-dependent apoptosis, which affects oogenesis 
directly by inducing oocyte apoptosis, or indirectly via somatic cell 
death and subsequent destruction of ovarian follicles. Impaired oogen-
esis can lead to reduced fecundity (Fig. 6). “Caspase expression” is 
considered an important KE, as caspases are key regulators of apoptosis 
(McIlwain et al., 2013) and the caspase-dependent apoptotic pathway 
has been associated with 5AC toxicity (Kiziltepe et al., 2007). Several 
caspase genes were upregulated in F0 after exposure, and the Casp2 
promoter methylation was consistently suppressed in F0 and F3 in the 
present study. In addition, the Casp2 pathway was ranked as one of the 
top influential toxicity pathways in both F0 and F3. The KE term is 
generalized to be applicable to more species with different caspases. In 
network 2, DNMT inhibition mediated global hypomethylation in F0 can 
be transmitted across generations to the unexposed (F3) progeny. 
Through a similar caspase-dependent apoptotic pathway to impair 
oogenesis, fecundity in F3 can be reduced and such transgenerational 
reproductive effect can lead to population decline. 
3.5.2. WoE assessment of KEs and KERs 
The two AOP networks consist of a total of 17 KEs (MIE and AO as 
special KEs) and 18 KERs (Fig. 6). Among the KEs, the essentialities of 
reduced “DNMT activity” (MIE), reduced “global DNA methylation” 
(KE1), increased “caspase expression”, “inherited DNA methylation in 
F3” (KE8), fecundity in F0 (AO1) and fecundity in F3 (AO2) are 
considered “High” (Fig. 6 and Appendix, Table A8), as these KEs are 
supported by direct evidence associated with DNMT inhibitor exposures 
by both present and previous studies. In contrast, the essentialities of 
increased “DNA DSB” (KE2) and decreased “population trajectory” 
(AO3) are considered “Moderate” (Fig. 6 and Appendix, Table A8), as no 
direct supporting evidence was obtained from the present study, 
whereas some indirect evidence exists in the literature (Kiziltepe et al., 
2007). The rest, especially the KEs associated with 5AC mediated effects 
at higher levels of biological organization (i.e., tissue/organ) and in F3, 
are scored as “Low” (Fig. 6 and Appendix, Table A8), as these are hy-
pothetical in the present study and are still lacking direct supporting 
evidence from the previous studies. Nevertheless, these KEs are high-
lighted as knowledge gaps and warrant further investigations. Among 
the 18 KERs, “reduced DNMT activity leading to reduced global DNA 
methylation”, “reduced global DNA methylation leading to increased 
caspase expression”, and “reduced global DNA methylation leading to 
inherited DNA methylation (F3)” were well supported by the current 
data and existing studies thus scored as “High”, whereas the rest with 
Fig. 6. Adverse Outcome Pathway (AOP) networks linking DNA methyltransferase (DNMT) inhibition to population decline. Network 1: One-generational AOP 
network for effects on F0. Network 2: Transgenerational AOP network for transmission of effects from F0 to F3. ↑: Increase; ↓: Decrease. Stars indicate the weight of 
evidence of key events (KE, black) and key event relationships (KERs, grey): 3 stars = high, 2 stars = moderate, 1 star = low. 
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Fig. 7. Multiple protein sequence alignment of the Daphnia magna DNA methyltransferase 3 (Dnmt3, A) and caspase 1 (Casp1, B) conserved domains with that in 
other taxa to define the taxonomic applicability domain of the Adverse Outcome Pathway (AOP) networks. Dashed lines indicate susceptibility cutoffs, above the line: 
susceptible; below the line: not susceptible. 
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partial supporting evidence are scored as “Moderate” (Fig. 6 and Ap-
pendix, Table A9). 
3.5.3. Applicability domains 
The AOPs are considered applicable to female animals at both ju-
venile and adult stages. The SeqAPASS analysis showed that the 
D. magna Dnmt3 (accession: KZS08978.1) conserved domain (accession: 
cd11725) had high protein sequence similarities to that of 32 taxonomic 
groups (439 species), of which 30 taxa (437 species) were considered 
susceptible groups to DNMT modulators (Fig. 7A and Appendix, 
Table A10). The MIE of the AOPs is therefore potentially applicable to a 
wide range of taxa, except for Lingulata and Hexanauplia. Alignment of 
the D. magna caspase 1 (accession: KZS14075.1) conserved domain 
(accession: cd00032) also showed high protein sequence similarities to 
48 taxa (704 species), of which 46 taxa (703 species) were considered 
susceptible (Fig. 7B and Appendix, Table A10). The KE of “caspase 
expression” is therefore potentially applicable to most species except for 
Reticulomyxidae and Haptophyceae. Chemicals that have previously 
been classified as DNMT inhibitors in different literatures are collected 
in a list as the chemical applicability domain of the AOPs (Appendix, 
Table A11). 
3.5.4. Potential applications of the AOPs 
The AOPs are applicable to a wide range of species/chemicals and 
can potentially be used to reduce future needs for toxicity testing of 
DNMT inhibitors. Besides DNMT inhibitors, the proposed AOPs may also 
serve as a mechanistic basis for understanding epigenetic effects medi-
ated by other environmental stressors which share common pathways. 
For instance, depletion of s-adenosyl methionine (SAM) as a conse-
quence of Arsenic exposure (Reichard and Puga, 2010) may likely lead 
to similar pathways downstream of DNMT inhibition in the proposed 
AOP networks. In the context of ecological hazard and risk assessment at 
the population level, epigenetic marks are considered sentinels of 
multigenerational population dynamics, and as such, potential early 
warnings for impact, or identifying possible barriers to population re-
covery following exposure to stressors. The proposed AOPs may aid such 
analyses by providing extensive mechanistic knowledge and multiple 
lines of evidence at different levels of biological organization. As AOPs 
are living documents (Villeneuve et al., 2014), these generalized models 
will be continuously refined with accumulating evidence. 
4. Conclusion 
The present study has integrated a high-throughput laboratory 
analytical workflow, Bayesian network modeling and bioinformatics to 
understand the transgenerational effects of DNMT inhibitors (5-azacy-
tidine) on aquatic organisms (water flea), and to support the develop-
ment of novel epigenetic AOP networks for cost-efficient ecological 
hazard and risk assessment of epigenetic modulators. The targeted lab-
oratory tests have generated substantial concentration-response and 
multigenerational data to provide in-depth mechanistic and quantitative 
insights into the hazards of DNMT inhibitors. The high-throughput 
analytical workflow developed by the present study can be easily 
adopted by others, as the required instrument is normally available in 
most laboratories. The Bayesian network assisted toxicity pathway 
characterization was presented as a novel data-driven approach to 
effectively identifying key information from high volume and complex 
(eco)toxicological data. The world’s first epigenetic AOP network 
models for aquatic organisms were developed and have great potentials 
to inform and improve future risk assessment of DNMT inhibitors and 
other epigenetic modulators, thus greatly reducing (eco)toxicological 
testing needs. The complete experimental and data analytical workflow 
presented by this study also sets a good example for future de novo AOP 
and quantitative AOP (qAOP) development and evaluation based on 
limited empirical data. 
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